Tango Therapeutics (TNGX) Tax Provisions (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly Tax Provisions of $1000.0 for Q1 2026, down 97.06% year-over-year from $34000.0 in Q1 2025, and up 101.79% quarter-over-quarter from -$56000.0 in Q4 2025.
Powered by 
Analysis
Tango Therapeutics (TNGX) Tax Provisions (2020 - 2026) Analysis & Trends
Tango Therapeutics' Tax Provisions history runs 7 years deep, the most recent figure standing at $1000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 97.06% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at -$30000.0 (down 114.85% YoY), while the FY2025 annual figure was $3000.0, down 98.56% from the prior year.
- Tax Provisions for Q1 2026 stood at $1000.0, up from -$56000.0 in the prior quarter.
- The five-year high for Tax Provisions was $100000.0 in Q2 2023, with the low at -$56000.0 in Q4 2025.
- The 5-year median for Tax Provisions is $34500.0 (2025), against an average of $32000.0.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions surged 3233.33% in 2023, then slumped 214.29% in 2025.
- Tango Therapeutics' Tax Provisions stood at $97000.0 in 2022, then plunged by 86.6% to $13000.0 in 2023, then soared by 276.92% to $49000.0 in 2024, then plunged by 214.29% to -$56000.0 in 2025, then surged by 101.79% to $1000.0 in 2026.
- Business Quant data shows TNGX's Tax Provisions at $1000.0 in Q1 2026, -$56000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Tango Therapeutics | 3.37 Bn | 2.35 Bn | - | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | -21.43 Mn |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Dec 31, 2022 | 97,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Dec 31, 2021 | 185,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Mar 31, 2021 | 74,000.00 |
| Dec 31, 2020 | 6,864.00 |